| Phase 2 multi-institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinoma | Cancer | 2015 | 334 |
| The Bacteroides fragilis toxin gene is prevalent in the colon mucosa of colorectal cancer patients | Clinical Infectious Diseases | 2015 | 289 |
| Androgens and diabetes in men: results from the Third National Health and Nutrition Examination Survey (NHANES III) | Diabetes Care | 2007 | 256 |
| Association between class III obesity (BMI of 40-59 kg/m2) and mortality: a pooled analysis of 20 prospective studies | PLoS Medicine | 2014 | 208 |
| Current topics in the epidemiology of oral cavity and oropharyngeal cancers | Head and Neck | 2007 | 198 |
| Plasma 1,25-dihydroxy- and 25-hydroxyvitamin D and subsequent risk of prostate cancer | Cancer Causes and Control | 2004 | 191 |
| Prostate size and risk of high-grade, advanced prostate cancer and biochemical progression after radical prostatectomy: a search database study | Journal of Clinical Oncology | 2005 | 186 |
| Sex steroid hormones and the androgen receptor gene CAG repeat and subsequent risk of prostate cancer in the prostate-specific antigen era | Cancer Epidemiology Biomarkers and Prevention | 2005 | 185 |
| Epidemiology of inflammation and prostate cancer | Journal of Urology | 2004 | 180 |
| Chronic inflammation in benign prostate tissue is associated with high-grade prostate cancer in the placebo arm of the prostate cancer prevention trial | Cancer Epidemiology Biomarkers and Prevention | 2014 | 160 |
| Genetic susceptibility to pancreatic cancer | Molecular Carcinogenesis | 2012 | 150 |
| PancPRO: risk assessment for individuals with a family history of pancreatic cancer | Journal of Clinical Oncology | 2007 | 150 |
| Prognostic factors for survival in adult patients with recurrent glioma enrolled onto the new approaches to brain tumor therapy CNS consortium phase I and II clinical trials | Journal of Clinical Oncology | 2007 | 149 |
| C-reactive protein and colorectal cancer risk: a systematic review of prospective studies | International Journal of Cancer | 2008 | 147 |
| Men with low serum cholesterol have a lower risk of high-grade prostate cancer in the placebo arm of the prostate cancer prevention trial | Cancer Epidemiology Biomarkers and Prevention | 2009 | 131 |
| Provider roles in the recruitment of underrepresented populations to cancer clinical trials | Cancer | 2007 | 123 |
| Association of IL10 and other immune response- and obesity-related genes with prostate cancer in CLUE II | Prostate | 2009 | 108 |
| Association between plasma cholesterol and prostate cancer in the PSA era | International Journal of Cancer | 2008 | 100 |
| Statin medication use and the risk of biochemical recurrence after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) Database | Cancer | 2010 | 96 |
| Statin use and breast cancer survival: a nationwide cohort study from Finland | PLoS ONE | 2014 | 91 |
| Serum C-reactive protein concentration and lower urinary tract symptoms in older men in the Third National Health and Nutrition Examination Survey (NHANES III) | Prostate | 2005 | 91 |
| Vitamin D receptor (VDR) gene polymorphisms and haplotypes, interactions with plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D, and prostate cancer risk | Prostate | 2007 | 88 |
| An absolute risk model to identify individuals at elevated risk for pancreatic cancer in the general population | PLoS ONE | 2013 | 82 |
| Trichomonosis and subsequent risk of prostate cancer in the Prostate Cancer Prevention Trial | International Journal of Cancer | 2009 | 71 |
| Acne and risk of prostate cancer | International Journal of Cancer | 2007 | 66 |
